Management of stage III non–small-cell lung cancer: ASCO guideline

ME Daly, N Singh, N Ismaila, MB Antonoff… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An …

Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis

C Billiet, H Decaluwé, S Peeters… - Radiotherapy and …, 2014 - Elsevier
Background We hypothesized that modern postoperative radiotherapy (PORT) could
decrease local recurrence (LR) and improve overall survival (OS) in patients with stage IIIA …

Guidelines on the radical management of patients with lung cancer

E Lim, D Baldwin, M Beckles, J Duffy, J Entwisle… - Thorax, 2010 - thorax.bmj.com
A joint initiative by the British Thoracic Society and the Society for Cardiothoracic Surgery in
Great Britain and Ireland was undertaken to update the 2001 guidelines for the selection …

Postoperative radiotherapy for stage II or III non–small-cell lung cancer using the surveillance, epidemiology, and end results database

BE Lally, D Zelterman, JM Colasanto… - Journal of clinical …, 2006 - ascopubs.org
Purpose To investigate the association between survival and postoperative radiotherapy
(PORT) in patients with resected non–small-cell lung cancer (NSCLC). Patients and …

Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non–small-cell lung cancer treated with adjuvant …

JY Douillard, R Rosell, M De Lena, M Riggi… - International Journal of …, 2008 - Elsevier
PURPOSE: To study the impact of postoperative radiation therapy (PORT) on survival in the
Adjuvant Navelbine International Trialist Association (ANITA) randomized study of adjuvant …

Local recurrence after surgery for early stage lung cancer: an 11‐year experience with 975 patients

CR Kelsey, LB Marks, D Hollis, JL Hubbs, NE Ready… - Cancer, 2009 - Wiley Online Library
BACKGROUND: The objective of the current study was to evaluate the actuarial risk of local
failure (LF) after surgery for stage I to II nonsmall cell lung cancer (NSCLC) and assess …

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non–small-cell lung …

KMW Pisters, WK Evans, CG Azzoli, MG Kris… - Journal of clinical …, 2007 - ascopubs.org
Purpose To determine the role of adjuvant chemotherapy and radiation therapy in patients
with completely resected stage IA-IIIA non–small-cell lung cancer (NSCLC). Methods The …

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non–small-cell lung cancer

SM Keller, S Adak, H Wagner… - … England Journal of …, 2000 - Mass Medical Soc
Background We conducted a randomized trial to determine whether combination
chemotherapy plus thoracic radiotherapy is superior to thoracic radiotherapy alone in …

Role of postoperative radiotherapy in resected non‐small cell lung cancer: A reassessment based on new data

C Le Péchoux - The oncologist, 2011 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Identify
patients with non‐small cell lung cancer who may benefit from postoperative radiotherapy …

Postoperative radiotherapy for non‐small cell lung cancer

S Burdett, L Rydzewska, J Tierney… - Cochrane database …, 2016 - cochranelibrary.com
Background The role of postoperative radiotherapy (PORT) in the treatment of patients with
completely resected non‐small cell lung cancer (NSCLC) was not clear. A systematic review …